Results 161 to 170 of about 15,328 (206)

Clinical characteristics of <i>Pneumocystis jirovecii</i> pneumonia in 20 non-HIV-infected patients. [PDF]

J Thorac Dis
Wang W, Mo Q, Yu Q, Ding X.
europepmc   +1 more source

Metagenomic next-generation sequencing to detect Pneumocystis jirovecii pneumonia in critically ill, HIV-negative children: a retrospective multicenter study. [PDF]

BMC Pulm Med
He L, Cheng Y, Huang L, Zhang Z, Zhang Q, Gong L, Li T, Lu X, Cai X, Yan G.   +9 more
europepmc   +1 more source

Evaluation of the ELITe InGenius PCR assay compared with immunofluorescence for Pneumocystis jirovecii detection in respiratory samples

Dätwyler I, Kuster H, Greiner MA, Meyer-Sauteur PM, Karrer UW, Tschumi F, Berger C, Chakrakodi B, Bosshard P, Zinkernagel AS, Kouyos RD, Günthard HF, Brugger SD.   +12 more
europepmc   +1 more source

What's Pneumocystis jirovecii?

What's Pneumocystis jirovecii?
openaire  

Transmission and Colonization of Pneumocystis jirovecii

Journal of Fungi (Basel, Switzerland), 2021
Pneumocystis spp. was discovered in 1909 and was classified as a fungus in 1988. The species that infects humans is called P. jirovecii and important characteristics of its genome have recently been discovered. Important advances have been made to understand P.
Zulma Vanessa Rueda, Rueda Zulma Vanessa
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Pneumocystis jirovecii

2010
The ascomycete fungus Pneumocystis jirovecii (previously called Pneumocystis carinii) is the cause of pneumocystis pneumonia (PCP) in humans, which occurs largely among people with impaired CD4+ T-lymphocyte function or numbers, e.g those infected with HIV, or organ transplant recipients taking therapeutic immunosuppressive agents.
Robert F. Miller, Laurence Huang
openaire   +2 more sources